manufacturers of glp 1 drugs GLP-1 Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care The Biggest Winner of GLP-1
Description
Effective treatments, like GLP-1 drugs, are rarely risk-free
Almost 30% of the events were reported by nonmedically trained individuals, which may affect the diagnostic accuracy of these findings
Bertoccini L, Baroni MG
If you are experiencing side effects you are not managing well, say so
Ozempic and Wegovy, made by Novo Nordisk, mimic the effects of GLP-1, a type of hormone in the body that impacts everything from the brain to muscle to the pancreas, stomach and liver, according to the National Institutes of Health
28% point to a lack of supply of the drugs, an issue that has been widely reported
